# CyberKnife for Unresectable Renal Tumors

> **NCT00807339** · NA · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 17 (actual)

## Conditions studied

- Renal Cancer

## Interventions

- **RADIATION:** Stereotactic radiation
- **DEVICE:** CyberKnife Robotic Radiosurgery System

## Key facts

- **NCT ID:** NCT00807339
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2014-01-01
- **Final completion:** 2014-08-20
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2017-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00807339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00807339, "CyberKnife for Unresectable Renal Tumors". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00807339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*